Lytvynova, O.; Jwayyed, J.; Pastel, D.; Prasad, R.; Khouri, J.; Williams, L.; Mazzoni, S.; Raza, S.; Anwer, F.
Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma. Antibodies 2024, 13, 80.
https://doi.org/10.3390/antib13040080
AMA Style
Lytvynova O, Jwayyed J, Pastel D, Prasad R, Khouri J, Williams L, Mazzoni S, Raza S, Anwer F.
Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma. Antibodies. 2024; 13(4):80.
https://doi.org/10.3390/antib13040080
Chicago/Turabian Style
Lytvynova, Olga, Jenna Jwayyed, Daniel Pastel, Rohan Prasad, Jack Khouri, Louis Williams, Sandra Mazzoni, Shahzad Raza, and Faiz Anwer.
2024. "Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma" Antibodies 13, no. 4: 80.
https://doi.org/10.3390/antib13040080
APA Style
Lytvynova, O., Jwayyed, J., Pastel, D., Prasad, R., Khouri, J., Williams, L., Mazzoni, S., Raza, S., & Anwer, F.
(2024). Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma. Antibodies, 13(4), 80.
https://doi.org/10.3390/antib13040080